DECR1 activators are a category of chemical agents designed to enhance the activity of DECR1, an enzyme formally known as 2,4-dienoyl-CoA reductase 1. This enzyme plays a pivotal role in lipid metabolism, specifically in the beta-oxidation pathway of unsaturated fatty acids. DECR1 functions to reduce the double bonds present at the 2,4 positions in polyunsaturated fatty acyl-CoA substrates, which is a necessary step for the proper degradation of these fatty acids. This biochemical process is crucial for maintaining the balance of lipid-based compounds within the cell and for the production of energy during periods of increased metabolic demand. The activators of DECR1 are thus involved in fine-tuning the enzyme's activity, ensuring that the beta-oxidation pathway operates efficiently. These compounds achieve this by binding to the enzyme and inducing conformational changes that result in an increased affinity for its substrates or by enhancing the enzyme's catalytic action, thereby facilitating a more rapid conversion of substrates into products.
The structural composition of DECR1 activators is diverse, reflecting the complexity of the enzyme's active site and the precise nature of the activation process. The activators are often small molecules that can penetrate cellular membranes to reach intracellular DECR1. They are characterized by functional groups that enable them to interact with specific amino acid residues within the enzyme's active site. These interactions may involve hydrogen bonding, hydrophobic interactions, and sometimes transient covalent bonds, which can stabilize the transition state of the substrate or reposition key residues within the enzyme to enhance its catalytic efficiency. The design of DECR1 activators is informed by detailed knowledge of the enzyme's three-dimensional structure, as revealed by techniques such as X-ray crystallography or nuclear magnetic resonance spectroscopy. By understanding the spatial arrangement of the enzyme's active site, chemists can tailor the chemical properties of the activators to ensure a high degree of specificity and potency in the activation of DECR1, which in turn can have a significant impact on the metabolism of unsaturated fatty acids within the cell.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, a polyphenolic compound, could potentially stimulate DECR1 expression by enhancing cellular energy metabolism, given its known role in metabolic pathway stimulation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
As a compound shown to enhance mitochondrial function, Curcumin might induce DECR1 expression by promoting mitochondrial efficiency and thus increasing fatty acid beta-oxidation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin, with its strong antioxidative properties, could potentially upregulate DECR1 expression by reducing oxidative stress and thus ensuring optimal mitochondrial functionality. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate, a potent antioxidant, might induce DECR1 expression by preserving mitochondrial functions under oxidative stress, thereby ensuring efficient fatty acid beta-oxidation. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $33.00 $73.00 $265.00 $112.00 | 34 | |
N-Acetyl-L-cysteine, acting as an antioxidant, might stimulate DECR1 expression by reducing oxidative stress, ensuring optimal mitochondrial function, and promoting fatty acid beta-oxidation. | ||||||
Coenzyme Q10 | 303-98-0 | sc-205262 sc-205262A | 1 g 5 g | $70.00 $180.00 | 1 | |
Coenzyme Q10, crucial for mitochondrial bioenergetics, might upregulate DECR1 expression by promoting efficient energy metabolism, thereby increasing the demand for fatty acid breakdown. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
Nicotinamide riboside, a precursor for NAD+, might increase DECR1 expression by promoting cellular energy metabolism through its role in redox reactions. | ||||||
Silymarin group, mixture of isomers | 65666-07-1 | sc-301806 | 50 g | $319.00 | ||
Silymarin, known for its antioxidative properties, could potentially upregulate DECR1 expression by reducing oxidative stress, ensuring optimal mitochondrial function, and thus promoting fatty acid beta-oxidation. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Berberine, known for its role in enhancing several metabolic pathways, might stimulate DECR1 expression by promoting energy metabolism, leading to an increased need for fatty acid breakdown. | ||||||
(+)-α-Tocopherol | 59-02-9 | sc-214454 sc-214454A sc-214454B | 10 g 25 g 100 g | $42.00 $61.00 $138.00 | ||
(+)-α-Tocopherol, an antioxidant, could potentially increase DECR1 expression by reducing oxidative stress, ensuring optimal mitochondrial function, and thus supporting fatty acid beta-oxidation. |